We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+3.19%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$2.63B
AUM Growth
+$79.2M
Cap. Flow
+$7.18M
Cap. Flow %
0.27%
Top 10 Hldgs %
23.53%
Holding
504
New
17
Increased
137
Reduced
154
Closed
30

Top Sells

Rank Stock Value
1
NWL icon
Newell Brands
NWL
+$4.94M
2
TGT icon
Target
TGT
+$2.67M
3
IBM icon
IBM
IBM
+$1.68M
4
GILD icon
Gilead Sciences
GILD
+$897K
5
GWW icon
W.W. Grainger
GWW
+$821K

Sector Composition

Rank Sector Weight
1 Healthcare 15.92%
2 Financials 13.21%
3 Industrials 11.82%
4 Technology 11.08%
5 Consumer Staples 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDX icon
101
Becton Dickinson
BDX
$43.1B
$5.26M 0.2%
27,618
+15,338
+125% +$2.8M
GWW icon
102
W.W. Grainger
GWW
$65.3B
$5.19M 0.2%
28,736
-4,349
-13% -$821K
AMT icon
103
American Tower
AMT
$77.7B
$5.13M 0.2%
38,773
-460
-1% -$58.9K
IJH icon
104
iShares Core S&P Mid-Cap ETF
IJH
$123B
$4.87M 0.19%
140,085
-230
-0.2% -$7.94K
EMR icon
105
Emerson Electric
EMR
$82.9B
$4.86M 0.18%
81,577
+1,970
+2% +$117K
SRCL
106
DELISTED
Stericycle Inc
SRCL
$4.86M 0.18%
63,691
+225
+0.4% +$18.5K
INTC icon
107
Intel
INTC
$464B
$4.77M 0.18%
141,453
-3,026
-2% -$108K
ACN icon
108
Accenture
ACN
$89.9B
$4.66M 0.18%
37,688
+290
+0.8% +$35.3K
CVS icon
109
CVS Health
CVS
$137B
$4.48M 0.17%
55,640
+965
+2% +$76.2K
IVV icon
110
iShares Core S&P 500 ETF
IVV
$876B
$4.4M 0.17%
18,075
+360
+2% +$86.9K
TGT icon
111
Target
TGT
$62.1B
$4.33M 0.16%
82,827
-48,806
-37% -$2.67M
RHT
112
DELISTED
Red Hat Inc
RHT
$4.22M 0.16%
44,097
+151
+0.3% +$13.5K
ITW icon
113
Illinois Tool Works
ITW
$81.4B
$3.96M 0.15%
27,663
+3
+0% +$418
SIVB
114
DELISTED
SVB Financial Group
SIVB
$3.95M 0.15%
22,460
-36
-0.2% -$6.45K
D icon
115
Dominion Energy
D
$62.5B
$3.84M 0.15%
50,083
-1,083
-2% -$85.1K
PX
116
DELISTED
Praxair Inc
PX
$3.83M 0.15%
28,901
-2,420
-8% -$310K
ADI icon
117
Analog Devices
ADI
$181B
$3.81M 0.14%
48,948
-200
-0.4% -$15.9K
DVY icon
118
iShares Select Dividend ETF
DVY
$24B
$3.77M 0.14%
40,889
ATH
119
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$3.77M 0.14%
75,986
+31,669
+71% +$1.62M
ADBE icon
120
Adobe
ADBE
$89.5B
$3.63M 0.14%
25,645
-298
-1% -$40.8K
ATR icon
121
AptarGroup
ATR
$8.45B
$3.61M 0.14%
41,562
+10
+0% +$823
AMGN icon
122
Amgen
AMGN
$203B
$3.46M 0.13%
20,073
-13
-0.1% -$2.11K
EL icon
123
Estee Lauder
EL
$29B
$3.45M 0.13%
35,955
+300
+0.8% +$27.5K
ACC
124
DELISTED
American Campus Communities, Inc.
ACC
$3.39M 0.13%
71,588
+479
+0.7% +$22.8K
WM icon
125
Waste Management
WM
$95.9B
$3.37M 0.13%
45,904
-175
-0.4% -$12.7K

Similar funds

Gofen & Glossberg's Q2 2017 Portfolio in Review

As of Q2 2017, Gofen & Glossberg held 504 positions worth $2.63B, up 3.1% from $2.55B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Gofen & Glossberg's Q2 2017 filing shows 17 new, 137 increased, 154 reduced and 30 closed positions. Its largest new stake was Lions Gate Entertainment Corp. Class B Non-Voting Shares: 67,438 shares worth $1.77M. The largest sale was Newell Brands, an estimated $4.94M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Gofen & Glossberg's largest Q2 2017 buy was Lions Gate Entertainment Corp. Class B Non-Voting Shares: 67,438 shares worth $1.77M.
  • Gofen & Glossberg added most to Johnson Controls International in Q2 2017, an estimated $3.65M increase.
  • Gofen & Glossberg's biggest Q2 2017 reduction was Target, cutting an estimated $2.67M.
  • Gofen & Glossberg fully exited Newell Brands in Q2 2017, selling an estimated $4.94M.
  • Gofen & Glossberg's ten largest holdings make up 24% of its $2.63B portfolio in Q2 2017.
  • Gofen & Glossberg opened 17 new positions and closed 30 in Q2 2017.
  • Gofen & Glossberg's portfolio value rose 3.1% quarter-over-quarter to $2.63B.

Based on Gofen & Glossberg's 13F filing for Q2 2017, filed 16 Aug 2017.